Sort
85,873 grants matching “alzheimers”
Type I Interferon induction of neuroinflammation mediates neuropsychiatric lupus
$1,407,090Michael Craig Carroll · Boston Children'S Hospital · R01 · FY2025 · AR
Bioinformatics and Data Management Core
$1,407,034Gregory W Carter · Indiana University Indianapolis · U54 · FY2020 · AG
Targeted physical and cognitive activity in a VR environment in older adults at risk for Alzheimer's disease
$1,406,971Judy Pa · University Of Southern California · R01 · FY2021 · AG
Targeted physical and cognitive activity in a VR environment in older adults at risk for Alzheimer's disease
$1,406,971Judy Pa · University Of Southern California · R01 · FY2020 · AG
Pathological and Functional Impact of Tauopathy in vivo
$1,406,959Karen E Duff · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P01 · FY2008 · NS
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$1,406,475Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG
Genetics of deep-learning-derived neuroimaging endophenotypes for Alzheimer's Disease
$1,406,276Degui Zhi · University Of Texas Hlth Sci Ctr Houston · U01 · FY2021 · AG
Mechanism of action of omega-3 fatty acids in brain injury
$1,406,161Nicolas Guillermo Bazan · Lsu Health Sciences Center · RC2 · FY2010 · AT
Cognitive impairment in Mexican Americans: a population-based study
$1,406,072Lewis B Morgenstern · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
UCLA ALZHEIMERS DISEASE RESEARCH CENTER
$1,406,022University Of California Los Angeles · P50 · FY2002 · AG
SilverBills: A Legal, Technical and Financial Tool for Aging LGBTQ+ Individuals with Impaired Cognition.
$1,405,894Marci Lobel-Esrig · Silverbills Inc. · R44 · FY2022 · AG
Multi-Site Neuroimage Harmonization for Personalized Brain Disorder Analysis
$1,405,587Mingxia Liu · Univ Of North Carolina Chapel Hill · RF1 · FY2022 · AG
Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers
$1,405,570Jasmeer P Chhatwal · Brigham And Women'S Hospital · R01 · FY2025 · AG
Understanding the role of senescence on post-operative neuroinflammation
$1,405,555Shyni Varghese · Duke University · RF1 · FY2025 · AG
University of Florida - Mt. Sinai Medical Center AD Research Center
$1,405,272Todd E. Golde · University Of Florida · P50 · FY2019 · AG
Medicinal Chemistry Core
$1,404,681Robert H Mach · University Of Pennsylvania · U19 · FY2022 · NS
Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials
$1,404,629Jessica Brooke Langbaum · Banner Health · R01 · FY2021 · AG
Increasing synaptic PSD-95, a neuroprotection approach against Alzheimer's disease
$1,404,443Kim Bohemie Dore · University Of California, San Diego · RF1 · FY2021 · AG
SPRINT MIND 2020
$1,404,351David M Reboussin · Wake Forest University Health Sciences · R01 · FY2021 · AG
ROLE OF GLIA IN NEURONAL DEGENERATION
$1,404,268Northwestern University · P01 · FY2004 · AG
'Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders'
$1,404,266Justin C McArthur · Johns Hopkins University · P01 · FY2016 · MH
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
$1,403,404Linda J Van Eldik · University Of Kentucky · U01 · FY2016 · AG
Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
$1,403,321Shijun Zhang · Virginia Commonwealth University · U01 · FY2024 · AG
Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
$1,403,321Shijun Zhang · Virginia Commonwealth University · U01 · FY2023 · AG
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,403,277Linda J Van Eldik · University Of Kentucky · R01 · FY2019 · AG